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Abstract  
 RNA interference (RNAi) is double-stranded RNA (dsRNA)-mediated 
mRNA degradation. RNAi has been widely used to investigate gene functions. 
Many methods to induce transient or stable RNAi have been developed. Transient 
RNAi can be induced by delivering of a long dsRNA or short interfering RNAs 
(siRNAs). Stable RNAi may be induced by introducing plasmids expressing a 
long or a short hairpin RNA. Both small and long RNAs have been used to induce 
transient RNAi in mouse oocytes. Nevertheless, only long hairpin-expressing 
system has been used to trigger stable RNAi in oocytes. Although, this system 
appeared to be highly efficient and specific, it has several disadvantages as 
complicated long inverted repeat cloning or limited possibility to test these vectors 
in the cell culture.  
Here, we constructed a short hairpin-expressing vector suitable for 
transgenic RNAi induction in mouse oocytes. The new vector, pTMP_ZP3_sh, 
was derived from a lentiviral short hairpin vector selected based on comparative 
study of different short hairpin-expressing plasmids.  
The pTMP_ZP3_sh vector was tested by targeting Moloney sarcoma 
oncogene (Mos) mRNA, which is a common model for RNAi in mouse oocytes. 
We designed several candidate short hairpin sequences and tested their efficacy. 
Subsequently, the most efficient one was selected and transgenic mice were 
prepared. 
Unfortunately, analysis of transgenic mice revealed that the short hairpin-
expressing transgene is silenced. The exact reasons of its silencing will be further 
investigated. Our results suggest that short hairpin-expressing system is not 
superior to currently available RNAi-inducing systems, because short hairpin 
selection is as time-consuming as long inverted repeat cloning. Long hairpin-
expressing vectors remain the most suitable tool for RNA interference-based 
functional studies in oocytes.  
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1 Abbreviations 
ANOVA analysis of variance 
AGO  Argonaute protein 
bp  base pair 
BSA  bovine serum albumin 
CMV  cytomegalovirus 
CP  crossing point 
DMEM Dulbecco’s modified Eagle medium 
dsRNA double-stranded RNA 
EGFP  enhanced green fluorescent protein 
GV  germinal vesicle 
HCG  human choriogonadotropine 
IFN  interferon 
LTR  long terminal repeat 
MAP kinase mitogen activated protein kinase 
MAZ  Myc-associated zinc finger protein 
MII  metaphase II 
miRNA microRNA 
Mos  Moloney sarcoma oncogene 
MPF  maturation promoting factor 
mRNA messenger RNA 
nt  nucleotide 
PBS  potassium phosphate buffer 
PCR  polymerase chain reaction 
PEG  polyethylenglycol 
PenStrep Penicillin and Streptomycin  
PGK  phosphoglycerate kinase 
PNK  polynucleotide kinase 
PKR  protein kinase R 
PMSG  pregnant mare’s serum gonadotropine 
PNI  pronuclear injection 
pol II  RNA polymerase II 
pol III  RNA polymerase III 
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qPCR  quantitative polymerase chain reaction 
RDRC  RNA-Directed RNA Polymerase Complex 
RIG-I  retinoic acid/inducible gene-I 
RISC  RNA-induced silencing complex 
RITS  RNA-Induced Transcriptional Silencing complex 
RNAi   RNA interference 
RT  reverse transcription 
SAP  Shrimp alkaline phosphatase 
SEM  standard error of the mean 
shRNA short hairpin RNA 
SIBR  synthetic inhibitory BIC-derived RNA 
siRNA  short interfering RNA 
SPF  specified pathogen free 
TGN  transgenic 
UTR  untranslated region 
ZP3  zona pellucida glycoprotein 3 
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2 Introduction 
2.1 RNA silencing 
RNA silencing is a set of eukaryotic mechanisms, in which short RNAs 
participate in regulation of gene expression. Short RNAs can regulate gene 
expression at different levels: transcriptional, posttranscriptional or translational. 
RNA silencing plays an important role during the development and as a defense 
mechanism against parasitic sequences. 
Sequence-specific mRNA degradation mediated by dsRNA, known as 
RNA interference (RNAi), was one of the discovered posttranscriptional RNA 
silencing mechanisms. RNAi was first observed in Caenorhabditis elegans (Fire, 
et al., 1998). Initially, scientists supposed that mRNA translational repression 
could be mediated by interaction with complementary RNA. Fire et al. revealed 
that not the antisense RNA but dsRNA caused gene silencing by degradation of 
mRNAs complementary to dsRNA. Since the time, the RNAi phenomenon was 
observed in many diverse organisms as insects (Kennerdell and Carthew, 1998), 
amphibians (Oelgeschlager, et al., 2000) and mammals (Svoboda, et al., 2000; 
Wianny and Zernicka-Goetz, 2000).  
RNAi (Fig. 1) takes place in the cytoplasm where a long dsRNA is cleaved 
by RNase III Dicer to 21 – 23 bp long dsRNAs called short interfering RNAs 
(siRNAs). siRNAs have two-nucleotide overhangs at 3´ends originating from 
Dicer cleavage. Overhangs are recognized by the PAZ domain of Argonaute 
proteins (AGO), which are main components of the RNA-induced silencing 
complex (RISC) (Lingel, et al., 2004). RISC is a ribonucleoprotein complex, 
which unwinds siRNA and binds one of its strands while the second strand is 
degraded. Strand selection depends on the thermodynamic stability of the siRNA 
ends. The RISC is preferentially loaded by the strand with less stable 5´end that 
contains more A-U pairs (Khvorova, et al., 2003). The loaded RISC finds and 
binds an mRNA complementary to the siRNA strand and cleaves the target 
mRNA in the middle of the complementary region.  
In parallel, another RNA silencing pathway, the microRNA pathway, was 
discovered. In this pathway, short RNA precursors are coded in the genome (see 
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the chapter 2.2 for details). While RNAi serves mainly as defensive mechanism 
against parasitic sequences, miRNAs are concerned in the control of development. 
Small RNAs and RNAi machinery also participate in silencing at the 
transcriptional level. Regulation of heterochromatin assembly involving RNAi 
components was described in yeast and plants (Martienssen, et al., 2005; 
Wassenegger, 2005). In Schizosaccharomyces pombe two complexes essential for 
heterochromatin formation in the centromeric region were described: RNA-
Directed RNA Polymerase Complex (RDRC) and RNA-Induced Transcriptional 
Silencing complex (RITS) (Motamedi, et al., 2004; Verdel and Moazed, 2005). In 
addition, several mutations in RNAi components in Drosophila melanogaster and 
Caenorhabditis elegans led to the disruption of heterochromatic silencing (Pal-
Bhadra, et al., 2004; Sijen and Plasterk, 2003). Although siRNA-induced 
transcriptional silencing has been reported in mammalian cells (Janowski, et al., 
2006; Kim, et al., 2006), the actual underlying silencing mechanism is still a 
matter of discussion. 
 
2.2 miRNA pathway 
The miRNA pathway (Fig. 1) is closely related to RNAi (Grishok, et al., 
2001). miRNAs are transcribed from the genome in the form of a hairpin-
containing precursor RNA (pri-miRNA) by RNA polymerase II (Lee, et al., 
2004a). Nuclear RNase III Drosha releases the hairpin (pre-miRNA) from the pri-
miRNA. Like Dicer, Drosha produces two-nucleotide overhangs at the 3´end. Pre-
miRNAs translocate to the cytoplasm via Exportin 5 (Lund, et al., 2004). A 
double-stranded stem structure longer than 16 bp and a short 3´overhang are 
required for successful transport (Zeng and Cullen, 2004). In the cytoplasm, pre-
miRNAs are cleaved by Dicer to release mature miRNAs. Mature miRNAs have 
the same length and similar structure as siRNAs, except that a miRNA duplex 
typically contains bulges. One miRNA strand is loaded into RISC complex, which 
mediates mRNA translational repression and/or mRNA degradation. Endogenous 
miRNAs are usually not perfectly complementary to target mRNAs, bind to 
3´UTRs and induce translational repression. The whole mRNA-RISC complex 
relocates to the cytoplasmic structures called P-bodies, where target mRNAs are 
stored and ultimately degraded.  
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Figure 1: RNA silencing pathways in mammals 
In both RNAi and miRNA pathways, short dsRNAs with 3´ overhangs arise after cleavage 
by Dicer. Whether these short RNAs cause mRNA degradation or translation repression 
depends on the level of short RNA-mRNA complementarity but not on the short RNA 
origin. However, endogenous miRNA are not usually perfectly complementary to mRNA 
and thus inhibit translation, while siRNAs usually mediate mRNA cleavage.  
 
2.3 RNAi in mammalian cells 
When RNAi was described in C. elegans, it was not expected RNAi could 
work in mammals, because even a small amount of dsRNA longer than 30 bp 
triggers a series of reactions generally called the interferon (IFN) response in 
mammalian somatic cells (Manche, et al., 1992). The activation of IFN pathway 
leads to translational repression, indiscriminate mRNA degradation and, 
eventually, apoptosis. The IFN response involves activation of a number of 
proteins, including protein kinase R (PKR), retinoic acid/inducible gene-I (RIG-I) 
and/or family of 2’-5’-oligoadenylate synthetases. dsRNA binding to domains at 
the amino acid terminus of PKR leads to conformation changes and to PKR 
activation by autophosphorylation. Activated PKR phosphorylates and inhibits 
translation initiation factor eIF2a, causing general repression of protein synthesis. 
dsRNA also activates 2´, 5´-oligoadenylate synthetase. Synthesized 
oligoadenylates induce dimerization and activation of the latent endonuclease 
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RNaseL. Active RNaseL indiscriminately degrades RNA in the cell. 
Oligoadenylate/RNaseL system can also induce apoptosis by degrading mRNAs 
coding anti-apoptotic or cell survival factors (reviewed in Barber, 2001). The IFN 
response is a defensive mechanism against viruses, which frequently produce 
dsRNA during their life cycle. Interestingly, oocytes and early embryos lack 
sequence-independent response to the long dsRNA (Stein, et al., 2005) and long 
dsRNA can thus induce specific RNAi in these cells (Svoboda, et al., 2000; 
Wianny and Zernicka-Goetz, 2000). It is unknown why oocytes and early embryos 
lack the IFN pathway. Interestingly, these are the only cells, where endogenous 
siRNAs have been detected so far (Watanabe, et al., 2008).  
In contrast to long dsRNA-induced RNAi, miRNAs and siRNAs are 
functional in all mammalian cells. The same enzymes and complexes involved in 
long dsRNA-triggered RNAi pathway mediate the action of both types of small 
RNAs. Mammals have only one Dicer and four AGO proteins (AGO1-4). The 
presence of a specific AGO protein in the RISC complex determines whether 
target mRNA is cleaved or not (Meister, et al., 2004). mRNA cleavage occurs only 
when the RISC complex contains AGO2 but not other AGO proteins (Meister, et 
al., 2004). Next to the AGO type, complementarity between miRNA/siRNA and 
its target plays an important role. Cleavage requires the perfect complementarity 
(Hutvagner and Zamore, 2002) while the presence of mismatches prevents 
cleavage but may result in translation repression.  
In some organisms, like Drosophila melanogaster, RNAi and miRNA 
pathways genetically diverged. Dicer-1 and AGO1 are involved in the miRNA 
pathway while Dicer-2 and AGO2 are specific for the RNAi pathway (Lee, et al., 
2004b; Okamura, et al., 2004). 
 
2.4 RNAi as an experimental tool 
Since its discovery, RNAi has become a powerful technique to inhibit gene 
function. Two ways to experimentally induce RNAi exist. The first one is based 
on delivering of exogenous siRNAs or long dsRNAs. However, resulting gene 
down-regulation is only transient. The second way is to use dsRNA-expressing 
system, which allows for transient or stable inhibition of the target gene. Particular 
RNAi-mediating systems are described later.  
9 
Before RNAi discovery, homologous recombination was the method of 
choice for gene silencing. In this method, a selection marker flanked by sequences 
homologous to the target gene is transfected into cells where it replaces the target 
gene during a homologous recombination, which takes place during mitosis 
(reviewed in Sedivy and Dutriaux, 1999). Such recombination inactivates the 
target gene and simultaneously enables selection of affected cells. However, 
Founder animals carry only one mutated allele, because the frequency of 
homologous recombination is very low. Therefore, gene targeting by homologous 
recombination requires inbreeding to obtain homozygous mutants, which makes 
the procedure even more time-consuming.  
In comparison to homologous recombination, RNAi provides several 
advantages. The main advantages of RNAi are speed and a favorable cost. RNAi 
may induce transient or stable silencing. Transient RNAi is relatively fast method 
suitable for using in cell cultures. In addition, preparation of animals with stable 
silencing provided by transgenic RNAi is also less time-consuming process 
compared to homologous recombination. Transgenic RNAi does not require 
breeding to obtain homozygotes in transgene, because it mediates down-regulation 
of transcripts from both corresponding chromosomes simultaneously. Moreover, 
while gene targeting by homologous recombination leads to complete gene 
silencing, RNAi mediates only partial silencing and remaining weak expression of 
target gene may prevent eventual lethality.  
Alternatively, conditional RNAi can be used to analyze genes whose 
knock-out is lethal at specific developmental stage. In this approach, the transgene 
is expressed from a tetracyclin-inducible promoter and its activity can be regulated 
by doxycyclin. Doxycyclin-mediated regulation is reversible and can be induced 
repeatedly. However, tetracycline-inducible regulation may not always be 100% 
reliable. 
 
2.4.1 RNAi in mouse oocytes 
Maternal mRNAs are transcribed during oocyte maturation and are stored 
in mature oocytes where no new RNA synthesis occurs. It is difficult to make a 
classic gene knock-out specifically in oocyte. RNAi is suitable for studying 
maternal mRNA function. Stored mRNAs are translated only upon resumption of 
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meiosis. So theoretically, there is long time for RNAi to totally degrade target 
maternal mRNA during the period when no fresh proteins are synthesized, whose 
prolonged stability might affect the overall RNAi efficacy in oocyte.  
 Moloney sarcoma oncogene (Mos) is well investigated maternal mRNA. 
Its well-characterized phenotype makes this gene a suitable target for development 
of RNAi-based methods. MOS is a protein kinase participating in meiosis 
regulation. MOS is active only in oocytes and is degraded upon fertilization. A 
negative regulatory sequence in the promoter of the Mos gene inhibits its 
expression in somatic cells. During oocyte development, MOS indirectly activates 
maturation promoting factor (MPF) via activation of mitogen activated protein 
(MAP) kinase. MOS inhibits proteolytic degradation of cyclin-B, thus leads to the 
accumulation of cyclin-B between meiosis I and II  and MPF activity remains high 
during metaphase arrest (reviewed in Heikinheimo and Gibbons, 1998). Mos 
knock-out expression leads to the disruption of the meiotic block in metaphase II 
and parthenogenetic activation of oocytes (Colledge, et al., 1994; Hashimoto, et 
al., 1994) leading to the extrusion of the second polar body without fertilization by 
the sperm, which provides a readily detectable phenotype.   
 
2.4.2 Nonspecific effects in RNAi experiments 
Although RNAi successfully down-regulates target gene expression in a 
sequence-specific manner, it can also cause unspecific changes in the expression 
of unrelated genes. siRNAs may function like endogenous miRNAs and bind 
3´UTR regions of transcripts with partial homology resulting in the repression of 
their translation. This undesirable effect is called off-targeting (Jackson, et al., 
2003; Persengiev, et al., 2004). Off-target effect can be reduced when the amount 
of an introduced siRNA is as low as possible and/or when a pool of siRNAs 
targeting the same gene but differing in their target sequences is used. Using a 
pool of siRNAs with the same total siRNA amount delivered, concentration of 
each individual siRNA from the pool is lower compared to single siRNA delivery. 
Lower siRNA concentration has reduced probability of off-targeting effects. The 
fact that a pool of siRNAs arising from a long dsRNA in oocytes does not evoke 
off-targeting supports this explanation (Stein, et al., 2005). 
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 Introducing the smallest possible amount of siRNAs (miRNAs) also 
prevents the saturation of the endogenous miRNA pathway, which may be 
detrimental for the cell. This problem becomes apparent when miRNAs-
mimicking hairpins (described later) are used to induce RNAi (Grimm, et al., 
2006). The critical point is the miRNA transport to the cytoplasm. Overexpressed 
recombinant pre-miRNAs seem to saturate Exportin 5 pathway and constrain the 
transport of endogenous pre-miRNAs into the cytoplasm and their further 
processing by Dicer (Grimm, et al., 2006). 
In addition, some specific nucleotide stretches, which stimulate immune 
response if contained within siRNA sequence, have been described (Hornung, et 
al., 2005; Judge, et al., 2005). Eventually, blunt-ended short dsRNAs can be 
recognized by RIG-I helicase and trigger immune response via activating the IFN 
pathway (reviewed in Marques and Williams, 2005). However, majority of short 
RNAs do not trigger IFN response in mammalian cells. 
 
2.4.3 Transient RNAi 
As mentioned above, transient RNAi can be triggered by delivering siRNAs 
or long dsRNA. Three delivery methods are commonly used in different model 
systems: transfection, electroporation and microinjection. Transfection and 
electroporation are typically used for experiments using cultured cells. Contrary to 
cell cultures, chemical transfection is difficult to use in mouse oocytes. 
Commercial transfection reagents are usually highly toxic for mouse oocytes 
(Svoboda, 2004). Lazer et al. described successful transfection of rat oocytes 
(Lazar, et al., 2004). Electroporation is a suitable method when more oocytes are 
needed to be targeted simultaneously (Grabarek, et al., 2002).  
Microinjection is the most common method of delivering nucleic acids into 
oocytes Pilot experiments using transient RNAi in oocytes were performed by 
microinjection of long dsRNA complementary to Mos mRNA. Subsequent real-
time PCR analysis confirmed sequence-specific Mos mRNA down-regulation 
(Svoboda, et al., 2000) confirming that dsRNA microinjection led to the strong 
and specific silencing in mouse oocytes. Since that time, many other genes were 
successfully down-regulated by delivering dsRNA or siRNAs into oocytes by 
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microinjection (Anger, et al., 2005; De La Fuente, et al., 2004; Gui and Joyce, 
2005; Svoboda, et al., 2004). 
 
2.4.4 Transgenic RNAi 
Many studies require stable or continuous inhibition of gene expression. 
This initiated a development of RNAi-mediating expression systems, which could 
be stably integrated in the genome. Most systems express transcripts with a hairpin 
structure (McManus, et al., 2002; Shinagawa and Ishii, 2003; Svoboda, et al., 
2001). Some others express sense and antisense RNA strands separately, but these 
systems do not seem to mediate RNAi efficiently (Miyagishi and Taira, 2002). 
Developed vectors can be divided according to the type of expressed hairpin into 
three categories: 1) long hairpin, 2) short hairpin (shRNA) and 3) miRNA-like 
hairpin (Fig. 2).  
 
Figure 2: Types of hairpins used for RNAi induction.  
Short hairpin (shRNA) and long hairpin arise from inverted repeat and make a perfect 
dsRNA. miRNA-like hairpins have the similar structure as endogenous miRNAs and 
contain bulges and mismatches in double-strand region. The figure is based on 
(McManus, et al., 2002). 
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 Hairpins differ in stem length, loop length and in the presence of 
mismatches in the stem structure (described later). All three types can induce 
transgenic RNAi in oocytes. RNA polymerase III as well as RNA polymerase II 
promoters may be used to control hairpin expression. Choice of hairpin and 
promoter type depends on a particular situation. Properties of individual hairpins 
and promoters are discussed later. 
 
2.4.4.1 Long hairpin expressing systems 
Long dsRNA hairpin arises by transcription of a large inverted repeat. The 
hairpin is usually at least 500 bp long and mimics a long dsRNA. The expression 
systems producing long hairpin are applicable only to oocytes, early embryos and 
stem cells in mammals where the IFN pathway in not induced (Svoboda, et al., 
2001; Yu, et al., 2004). However, long hairpins are commonly used in RNAi 
experiments in invertebrates (Kennerdell and Carthew, 2000; Tavernarakis, et al., 
2000) and plants (Wesley, et al., 2001).  
 Long hairpin expression elicits the same inhibitory effect as microinjected 
dsRNA in oocytes (Stein, et al., 2003). This system is highly efficient and 
unspecific effects were not found (Stein, et al., 2005). So far, only long hairpins 
have been used to mediate transgenic RNAi in mouse oocytes. Several long 
hairpin-expressing systems have been constructed. The simplest system contains a 
promoter followed by an inverted repeat (Svoboda, et al., 2001). More advanced 
systems contain also reporter genes such as enhanced green florescent protein 
(EGFP) (Svoboda, et al., 2001). Although long 3´overhangs block RNAi in vitro 
(Elbashir, et al., 2001b), long 3´or 5´ overhangs do not apparently limit RNAi in 
vivo, so one promoter can simultaneously drive hairpin and marker expression 
(Svoboda, et al., 2001). However, mutual position of hairpin and marker coding 
sequences influences marker expression (Svoboda, et al., 2001). The hairpin 
expression was not influenced by the position of EGFP coding sequence, but 
EGFP expression was detectable only when localized upstream of the hairpin. 
Introduction of an intron sequence next to the EGFP increased its expression, but 
an intron localized next to the hairpin blocked RNAi. A system containing an 
intron and EGFP followed by an inverted repeat appeared to be the most effective 
(Svoboda, et al., 2001) and it was chosen for transgenic RNAi (Stein, et al., 2003). 
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Shinagawa and Ishii presented an alternative system generating long 
hairpin, which should not trigger IFN response in mammalian somatic cells 
(Shinagawa and Ishii, 2003). Long dsRNA triggers IFN response after its transport 
to the cytoplasm (Stark, et al., 1998). Polyadenylation of the 3´ end and 5´ cap are 
required for successful transport of RNA to the cytoplasm. If these structures are 
excised, transcript is retained in the nucleus. In their system, Shinagawa and Ishii 
flanked long hairpin-coding inverted repeat with a ribozyme sequence at the 5´end 
and with Myc-associated zinc finger protein (MAZ) sequence at the 3´end. The 
ribozyme cut off 5´cap and the presented MAZ sequence terminated transcription 
prematurely. Produced long hairpin RNA was probably digested by Dicer present 
in the nucleus and siRNAs were transported to the cytoplasm. This system was 
used for successful down-regulation of Ski gene expression in mouse embryos 
without triggering the immune response (Shinagawa and Ishii, 2003). 
 
2.4.4.2 Short hairpin expressing systems 
Short hairpin-expressing vectors have been used since 2002 
(Brummelkamp, et al., 2002; McManus, et al., 2002). Short expressing systems 
are able to mediate RNAi in all mammalian cells contrary to the long hairpins, 
which function only in oocytes and early embryos. Other advantage of short 
hairpins is their easier cloning compared to long ones.  
A variety of short hairpin-expressing vectors have been described since 
then (Coumoul, et al., 2005; Gupta, et al., 2004; Chung, et al., 2006; Stern, et al., 
2008; Ventura, et al., 2004; Xia, et al., 2006). Short hairpin-expressing systems 
can be divided into class I and II (McManus, et al., 2002).  
Class I hairpins, usually called short hairpin RNAs (shRNA), contain 
perfectly complementary 19-21 bp long stem structure and 4 – 9 nt long loop. If 
the loop is placed between the 3´end of the strand complementary to target mRNA 
(antisense strand) and the 5´end of the passenger strand, the hairpin triggers RNAi 
as efficiently as corresponding synthetic siRNA. In the opposite orientation, the 
hairpin RNAi efficiency is impaired (McManus, et al., 2002). Class I hairpin 
expression is usually driven by RNA polymerase III-dependent promoters (for 
details see the chapter 2.4.4.2.1). 
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Class II hairpins mimic endogenous miRNAs and they are often called 
miRNA-like hairpins (Dickins, et al., 2005). These hairpins are typically 
transcribed by RNA polymerase II. Stem structure of these hairpins also contains 
bulges and mismatches. RNases Drosha and Dicer are involved in class II hairpin 
maturation (for details see the chapter 2.4.4.2.2). 
Other small RNA-expressing systems were described. The system 
developed by Miyagishi and Taira (Miyagishi and Taira, 2002) expresses siRNA 
strands separately from two independent promoters. However, this system is not 
commonly used.  
 
2.4.4.2.1 RNA polymerase III (Pol III) expression systems  
Pol III systems are predominantly used to express class I shRNAs, but may be 
used for the expression of miRNA-like hairpins as well. Hairpin expression is 
typically driven by U6 or H1 promoters. The main advantage of pol III is the 
precisely defined transcription termination. A stretch of thymidines directly 
following the hairpin sequence provides the transcription stop signal and creates 
TT 3´overhang.  
The major disadvantage of pol III systems is the difficulty to achieve 
tissue-specific hairpin expression, since there are no tissue-specific pol III 
promoters. Pol III-mediated tissue-specific expression may be achieved indirectly 
by Cre-loxP systems. In Cre-activated systems, the loxP-flanked sequence of a 
marker (e.g. EGFP gene) is placed between the promoter and shRNA coding 
sequence. Thus, shRNA is expressed only after Cre-mediated deletion of the loxP-
flanked marker sequence (Coumoul, et al., 2005; Ventura, et al., 2004).  
In Cre-inactivated systems, loxP sites flank shRNA coding sequence, 
whose deletion upon recombination leads to the lost of silencing (Ventura, et al., 
2004). Breeding of transgenic mice containing loxP-flanked shRNA cassette with 
a mice expressing Cre recombinase in selected tissue allows for tissue-specific 
shRNA expression in vivo. The disadvantage of these Cre-loxP regulated systems 
is that achieving tissue-specific shRNA expression requires extensive breeding 
and that Cre-mediated recombination changes are irreversible. 
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2.4.4.2.2 RNA polymerase II (Pol II) expression systems 
 Class II miRNA-like hairpins are expressed by RNA polymerase II 
similarly to endogenous miRNAs (Lee, et al., 2004a). In comparison to pol III 
systems, higher expression levels of miRNA-like hairpins are achieved from pol II 
promoters (Dickins, et al., 2005) and a wide range of tissue-specific pol II 
promoters are available. Most pol II systems are based on human miR-30 
sequence, which was analyzed in detail in Bryan Cullen’s laboratory (Zeng and 
Cullen, 2003). The miR-30 precursor creates an approximately 80 nt long hairpin 
structure, which contains many bulges and mismatches. Irregular structure 
probably avoids triggering of IFN response (Bridge, et al., 2003). In pol II 
systems, sequence corresponding to mature miR- 30 is replaced by target gene 
sequence, while flanking sequences are preserved. These sequences contain 
regions recognized by nuclear RNase Drosha (Chen, et al., 2004). miRNA-like 
hairpins with the most similar secondary structure to the original miR-30 work 
more efficiently then structurally distorted hairpins (Zhou, et al., 2005). Some 
endogenous miRNAs reside in introns of protein coding genes. Thus, pol II 
systems allowing simultaneous expression of a hairpin and a marker gene from a 
single promoter were constructed (Chung, et al., 2006; Xia, et al., 2006).  
Chung et al. developed a vector using the mouse non-coding BIC sequence. The 
third BIC exon contains miR-155 precursor, which has been used for the 
construction of the synthetic inhibitory BIC-derived RNA (SIBR) cassette 
expressing miRNA-like hairpin. SIBR cassette can be embedded within an exon as 
well as an intron, but its expression from intron is stronger (Chung, et al., 2006). 
Multiple SIBR cassettes expressing different shRNAs targeting one or more 
gene(s) can be expressed from a single promoter. Such arrangement was proved to 
lower off-targeting and enhance RNAi effect (Chung, et al., 2006).  
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2.4.4.3 Aims of diploma thesis 
The major aim of this study was to develop an shRNA-expressing system 
mediating transgenic RNAi in mouse oocytes. The issue was approached through 
the following steps (Fig. 3): 
• selection the most appropriate shRNA expression system  
• design and selection of functional shRNA hairpin(s) targeting the mouse 
Mos gene 
• construction of a vector expressing Mos-targeting shRNA specifically in 
oocytes 
• production of transgenic mouse line(s) 
• phenotype analysis of transgenic animals 
 
 
 
 
Figure 3: Thesis project outline 
The thesis aim was approached by several indicated stepwise goals. We selected 
suitable shRNA-expressing vector and performed changes to make oocyte-specific 
expression system. We designed functional Mos-targeting shRNA hairpin(s) and inserted 
into prepared vector. Finally, transgenic mouse lines were established and analyzed.  
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3 Materials and methods 
3.1 Instruments 
Centrifuge 5424 (Eppendorf) 
Centrifuge 5415 R (Eppendorf) 
Centrifuge BR4i (Jouan) 
Electrophoresis HE 33 Mini Submarine Unit (Amersham Biosciences)  
Electrophoresis D3-14 Wide Gel System (Thermo Scientific) 
Vortex Mixer VX-100 (Labnet) 
Electroporator Gene Pulser (BioRad) 
Spectrophotometer NanoDrop ND-1000 
Thermocycler XP (Bioer) 
Thermocycler iQ5 (BioRad) 
Shaker 311DS (Labnet) 
Incubator shaker Innova 4000 (New Brunswick Scientific) 
Biological thermostat BT 120M (Laboratorní přístroje Praha) 
Laminar flow box Bio-II-A (Telstar) 
Incubator Model 321 (Thermo Electron Corporation) 
Microscope SZX16 (Olympus) 
3.2 Primers and oligonucleotides 
5´loxP.fwd GAT CGC GGC CGC ATA ACT TCG TAT AAT GTA 
TGC TAT ACG AAG TTA TA 
5´loxP.rev GAT CTA TAA CTT CGT ATA GCA TAC ATT ATA 
CGA AGT TAT GCG GCC GC 
3´loxP.fwd TCG ACA ATA AAA TAA CTT CGT ATA ATG TAT 
GCT ATA CGA AGT TAT GCG GCC GCG 
3´loxP.rev TCG ACG CGG CCG CAT AAC TTC GTA TAG CAT 
ACA TTA TAC GAA GTT ATT TTA TTG  
LMP_MunI.fwd CCA ACA GAA GGC TCG AGC AAC CAC AAT TGA 
AGG GGC TAC TTT AGG AGC AAT TAT CTT GTT 
TAC 
LMP_MunI.rev GTA AAC AAG ATA ATT GCT CCT AAA GTA GCC 
CCT TCA ATT GTG GTT GCT CGA GCC TTC TGT 
TGG 
ZP3_BglII_Fwd GAC AGA TCT CTG GGA GTT CAA GGC CAG 
ZP3_BglII_Rev GAG AGA TCT TAA TGA GAG GCT GAC ACC ACT 
G 
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LMP_oligo.fwd CAG AAG GCT CGA GAA GGT ATA TTG CTG TTG 
ACA GTG AGC G 
LMP_oligo.rev CTA AAG TAG CCC CTT GAA TTC CGA GGC AGT 
AGG CA 
FL_1 TGC TGT TGA CAG TGA GCG ACG TAC GCG GAA 
TAC TTC GAA ATA GTG AAG CCA CAG ATG TAT 
TTC GAA GTA TTC CGC CTA CGG TGC CTA CTG 
CCT CGG A 
FL_2 GAT CCC CCG TAC GCG GAA TAC TTC GAT TCA 
AGA GAT CGA AGT ATT CCG CGT ACG TTT TTA  
FL_3 AGC TTA AAA ACG TAC GCG GAA TAC TTC GAT 
CTC TTG AAT CGA AGT ATT CCG CGT ACG GGG 
FL_4 GCT GAT TTC GAA GTA TTC CGC GTA CGT TTT 
GGC CTC TGA CTG ACG TAC GGG AAA CTT CGA 
AAT C 
FL_5 TCC TGA TTT CGA AGT TTC CCG TAC GTC AGT 
CAG AGG CCA AAA CGT ACG CGG AAT ACT TCG 
AAA T 
LMP_Rev_Seq CTC CAG ACT GCC TTG GGA AAA GC 
LMP_Fwd_Seq CCT CAT CAC CCA GGT TAA GAT 
ZP3_end.fwd TAA GAA CAG TGG TGT CAG CCT C 
Mos_1 TGC TGT TGA CAG TGA GCG AAC GAC AAC ATA 
GTT CGG GTT GTA GTG AAG CCA CAG ATG TAC 
AAC CCG AAC TAT GTT GTC GTG TGC CTA CTG 
CCT CGG A 
Mos_2 TGC TGT TGA CAG TGA GCG ACC GAA GAC TCC 
AAC AGC CTA GTA GTG AAG CCA CAG ATG TAC 
TAG GCT GTT GGA GTC TTC GGG TGC CTA CTG 
CCT CGG A 
Mos_A TGC TGT TGA CAG TGA GCG AGG AGA TCC TGA 
AAG GAG AGA TTA GTG AAG CCA CAG ATG 
TAA TCT CTC CTT TCA GGA TCT CCG TGC CTA 
CTG CCT CGG A 
Mos_B TGC TGT TGA CAG TGA GCG CCC ATA GAC TGG 
GAA CAG GTA TTA GTG AAG CCA CAG ATG TAA 
TAC CTG TTC CCA GTC TAT GGA TGC CTA CTG 
CCT CGG A 
Mos_C TGC TGT TGA CAG TGA GCG AAG GGT TTG GCT 
CGG TGT ATA ATA GTG AAG CCA CAG ATG TAT 
TAT ACA CCG AGC CAA ACC CTC TGC CTA CTG 
CCT CGG A 
Mos_D TGC TGT TGA CAG TGA GCG CCC GGA GAT CCT 
GAA AGG AGA GTA GTG AAG CCA CAG ATG 
TAC TCT CCT TTC AGG ATC TCC GGA TGC CTA 
CTG CCT CGG A 
Mos_E TGC TGT TGA CAG TGA GCG ATC GGT GTA TAA 
AGC CAC TTA CTA GTG AAG CCA CAG ATG TAG 
TAA GTG GCT TTA TAC ACC GAG TGC CTA CTG 
CCT CGG A 
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Mos_F TGC TGT TGA CAG TGA GCG CGG GTT TGG CTC 
GGT GTA TAA ATA GTG AAG CCA CAG ATG TAT 
TTA TAC ACC GAG CCA AAC CCT TGC CTA CTG 
CCT CGG A 
OcAGlobin55.Fwd GCA GCC ACG GTG GCG AGT AT 
OcAGlobin312.Rev GTG GGA VAG GAG VTT GAA AT 
Mos2.Fwd GGG AAC AGG TAT GTC TGA TGCA 
Mos2.Rev CAC CGT GGT AAG TGG CTT TAT ACA 
 
3.3 Plasmid cloning 
3.3.1 Bacterial strains 
DH5α –electrocompetent cells (Invitrogen) 
MDS42 RecA Blue cells (Scarab Genomics) 
XL1-Blue supercompetent cells (Stratagene) 
XL10-GOLD competent cells (Stratagene) 
 
3.3.2 Commercial kits 
Zyppy™ Plasmid Miniprep Kit (Zymo Research) 
QIAprep Spin Miniprep Kit (Qiagen) 
GeneJET™ Plasmid Miniprep Kit  (Fermentas) 
NucleoBond Xtra Midi (Machery - Nagel) 
HiSpeed Plasmid Midi Kit (Qiagen) 
QIAquick Gel Extraction Kit (Qiagen) 
Zymoclean™ Gel DNA Recovery Kit (Zymo Research) 
DNA Clean & Concentrator™ (Zymo Research) 
Quick Change II XL Site-Direct Mutagenesis Kit (Stratagene) 
 
3.3.3 Chemical transformation 
A mixture of 1- 5 µl of a plasmid diluted in water and 50 µl of competent 
bacteria was placed in a 1.5 ml microtube and incubated on ice for 30 minutes, 
then at 42 ºC for 30 seconds. After 2 minutes on ice 450 µl of LB media (20 g/l) 
was added and the mixture was shaken at 37 ºC and 600 rpm for 1 hour in the 
mixing block. The culture was plated on a LB agar (15 g/l) containing Ampicilin 
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(100 µg/ml). Plates were incubated at 37 ºC overnight. Single colonies were 
picked up and inoculated into LB media (3-4 ml for Miniprep or 50-80 ml for 
Midiprep) with Ampicilin (100 µg/ml) and incubated at 37 ºC and 250 rpm 
overnight. Plasmids were isolated using one of the commercial Mini- or Midiprep 
kits specified above according to the manufacturer’s instructions. 
 
3.3.4 Electroporation  
A mixture of 1 µl plasmid and 50 µl bacteria was placed to the 
electroporation cuvette (Bio-Rad) and electroporated (pulse: 12.5 kV/cm, time 
constant: 4.4 – 5.0 msec) on the Gene Pulser (Bio-Rad). Immediately after the 
pulse, 950 µl of LB media was added and culture was incubated in 14 ml tube at 
37 ºC and 250 rpm for 1 hour. The culture was plated on a LB agar containing 
Ampicilin. Plates were treated as described above. 
 
3.3.5 Glycerol stocks 
Important bacterial cultures were stored as glycerol stocks at -80 °C. 0.25 
ml of 60% glycerol was mixed with 0.75 ml bacteria culture in cryotubes and 
placed in a -80 °C freezer immediately after glycerol addition. 
 
3.3.6 Restriction cleavage and dephosphorylation 
For restriction digests, 1 – 2 µg of a plasmid was mixed with 0.5 – 1 µl of a 
restriction endonuclease (usually 10 U/µl, Fermentas or New England Biolabs) 
and corresponding buffer. Water was added up to the total volume of 20 µl. The 
mixture was incubated at 37 ºC for 1 hour. If dephosphorylation was required, 8 µl 
of water, 1 µl of the restriction buffer used and 1 µl of the Shrimp Alkaline 
Phosphatase (SAP, Fermentas) were added. The mixture was incubated at 37 ºC 
for additional 30 minutes and then at 65 ºC for 15 minutes to inactivate SAP. 
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3.3.7 Ligation 
A cleaved vector (~ 50 ng) and an insert were mixed with T4 ligase buffer 
(1x), 2 µl polyethylenglycol (PEG) 4000, 1 µl T4 ligase (Fermentas) and water to 
total volume 20 µl. Concentration of insert ends was at least three-fold higher than 
concentration of vector ends. The mixture was incubated overnight in water bath 
at 16 ºC or for 1 hour at room temperature.  
 
3.3.8 Oligonucleotides annealing 
Oligonucleotides (2 µg each) were added into 100 µl of water. 
Oligonucleotides were annealed in a gradually cooling water bath (1 liter) after 
boiling for 5 minutes. Alternatively, oligonucleotide mixture was incubated in a 
thermocycler for 5 minutes at 95 ºC and then the thermocycler was turned-off to 
allow for gradual cooling. 
If phosphorylation was required, the following reaction was set up prior to 
annealing: 
 
Oligonucleotide in water  15 µl (2 µg) 
T4 ligase Buffer   2 µl 
ATP (100mM)   2 µl 
T4 Polynucleotide Kinase (PNK) 1 µl 
 
 The mixture was incubated at 37 ºC for 20 minutes. Then, PNK was 
inactivated at 75 ºC for 10 minutes. Phosphorylated oligonucleotides were 
annealed as described above. 
 
3.3.9 Mutagenesis 
Quick Change II XL Site-Direct Mutagenesis Kit (Stratagene) was used to 
introduce single nucleotide mutations. Primers containing mutations were 
designed according to the manufacturer’s instructions. PCR reaction for 
incorporating a mutation was following: 
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Plasmid DNA in water (50 ng) 30 µl 
Buffer (10x)    5 µl 
Primer.fwd (125 ng)   5 µl 
Primer.rev (125 ng)   5 µl 
Quick Solution   3 µl 
dNTP mix    1 µl 
Pfu Ultra polymerase   1 µl 
 
PCR parameters: 95 ºC for 4 minutes; 18 cycles of 95 ºC for 30 seconds, 58 ºC for 
1 minute, 68 ºC for 12 minutes; 68 ºC for 7 minutes and 4 ºC until samples were 
removed from the thermocycler. 
 The PCR product was cleaved by DpnI restriction enzyme to degrade non-
mutated plasmids. 1 µl of DpnI was added to 10 µl of PCR reaction. Mixture was 
incubated at 37 ºC for 2 hours. Subsequently, XL10-GOLD competent cells (30 
µl) provided with Mutagenesis kit were chemically transformed with mutated 
plasmids. 
All introduced mutations were verified by sequencing (Laboratory of DNA 
Sequencing, Faculty of Science, Charles University in Prague). 
   
3.4 Electrophoresis 
Instruments:  
HE 33 Mini Submarine Unit (Amersham Biosciences) 
D3-14 Wide Gel System (Thermo Scientific)  
 
Chemicals:  
UltraPure Agarose (Invitrogen) 
SeaKem LS Agarose (Lonza) 
 
TBE buffer:  
89 mM Tris 
89 mM boric acid 
2 mM EDTA 
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LB buffer:   
5mM lithium borate  
 
1% or 1.5% agarose in TBE or LB buffer with ethidium bromide (250 µg/l) 
was used for size-separation of DNA fragments. Commercial 1 kbp or 100 bp 
DNA ladder (Fermentas or NEB) served to determine fragments size. When some 
fragment was required for further processing, it was excised from the gel and 
DNA was isolated using one of the gel extraction kits according to the 
manufacturer’s instructions. 
 
3.5 Polymerase chain reaction (PCR) 
PCR reactions were prepared as follows:  
 
DNA in water (200 ng)  33 µl 
Primer.fwd (10 µM)   3 µl 
Primer.rev (10 µM)   3 µl 
Pfu buffer without Mg (10x)   5 µl 
MgSO4 (25mM)   4 µl 
dNTP´s (12.5 mM)   1 µl 
Pfu polymerase   1 µl 
 
All reagents were obtained from Fermentas. 
PCR reaction conditions were following: 94 ºC for 4 minutes; 12 cycles of 
94 ºC for 30 seconds, 57 ºC for 1 minutes, 68 ºC for 1 minute per 1 kb sequence; 
68 ºC for 3 minutes and 18 ºC until samples were removed from the thermocycler. 
 
3.5.1 Quantitative real-time RT-PCR (qPCR) 
qPCR was used for the analysis of mRNA expression in oocytes. 
Individual oocytes were collected separately in 5 µl of water. 1 µg of stuffer rRNA 
(16S + 23S, Roche) and 15 pg of external standard rabbit β-globin mRNA (Sigma) 
were added to each sample. All samples were snap-frozen and stored at -80 °C 
until further processing. Before qPCR, samples were incubated at 85 °C for 5 
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minutes to lyse oocytes and then were placed on ice. 1 µl of Oligo(dT) primer (50 
µM) and water up to 13 µl were added to all samples. Mixtures were incubated for 
5 minutes at 65 °C and placed directly on ice for at least 1 minute. Reverse 
transcriptase master mix (7 µl) was added into each sample:  
 
5X Reaction buffer (Fermentas)      4 µl 
dNTPs (10mM)        1 µl 
DTT 0.1 M         1 µl 
RiboLock RNase Inhibitor (40U/µl) (Fermentas)    0.5 µl 
RevertAid M-MuLV Reverse transcriptase (200 U/µl) (Fermentas) 0.5 µl 
 
Reverse transcriptase was omitted in control (-RT) samples.  
For cDNA synthesis, samples were incubated for 60 minutes at 42 °C, 
followed by 10 minutes incubation at 50 °C. Resulting cDNA was diluted 3:2 with 
water. A 3 µl aliquot of prepared cDNA was used as a template for qPCR. qPCR 
was performed on the Bio-Rad iQ5 machine using Maxima SYBR Green qPCR 
Master Mix (Fermentas). Specific primers for mouse Mos (Mos2.Fwd, Mos2.Rev) 
and rabbit β-globin mRNAs (OcAGlobin55.Fwd, OcAGlobin312.Rev) were used 
(for sequences see the chapter 3.2). Final PCR reaction mix was as follows: 
 
Maxima SYBR Green qPCR Master Mix (2X)  5 µl 
Primers mixture (Fwd and Rev; 2 µM each)   2 µl 
cDNA        3 µl 
 
qPCR reactions were cycled 50 times at 95 °C for 15 seconds, 60 °C for 20 
seconds, 72 °C for 30 seconds; final extension 10 minutes at 72 °C was performed. 
qPCR data were analyzed by the iQ5 software (Bio-Rad) and values of crossing 
points (CPs) were evaluated for each reaction. PCR efficiency was calculated for 
each individual reaction using the exponential regression model (Tichopad, et al., 
2003). CPs values were corrected according to particular reaction efficiency. 
Statistical significance of changes of Mos mRNA levels normalized to the external 
β-globin standard were analyzed by the pair-wise fixed reallocation randomization 
test using the REST 2008 software (Pfaffl, et al., 2002). 
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3.6 Tissue culture 
3.6.1 Cell lines 
HeLa - human epithelial cells from a cervical carcinoma transformed by human 
papillomavirus 18 (HPV18) 
HEK293 - human embryonic kidney cell line 
NIH3T3 - mouse fibroblast cell line established from Swiss mouse embryo tissue 
 
3.6.2 Solutions  
Dulbecco’s Modified Eagle medium (DMEM, 2x): 
Component g/l  Component g/l 
NaCl 12.8 L serine 0.084 
KCl 0.8 L threonine 0.19 
CaCl2.2H2O 0.53 L tryptophan 0.032 
MgSO4.7 H2O 0.4 L tyrosine 2Na H2O 0.2076 
Fe(NO3)3.9 H2O 0.0002 L valine 0.188 
NaH2PO4 0.2156 Folic acid 0.008 
L arginine HCl 0.168 D-Ca pantothenate 0.008 
L cysteine 2HCl 0.1252 choline chloride 0.008 
Glycine 0.06 Myo-inositol 0.0144 
L histidine HCl H2O 0.084 Niacinamide 0.008 
L isoleucine 0.21 Pyridoxal HCl 0.008 
L leucine 0.21 Ribofavin 0.0008 
L lysine HCl 0.292 Thiamine 0.008 
L methionine 0.06 Glucose 9 
L phenylalanine 0.132 Phenol red 0.032 
 
Phosphate-buffered saline (PBS; 1x): 
Component g/l 
NaCl 8 
KCl 0.2 
KH2PO4 0.2 
Na2HPO4 1.15 
 
3.6.3 Cell culture 
Cells were cultured in DMEM supplemented with 10 % fetal bovine serum 
(FBS), Penicillin 100 U/ml and Streptomycin 100 µg/ml. All reagents were 
obtained from Media service of Institute of Molecular Genetics, Academy of 
Science of the Czech Republic. 
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3.6.3.1 Transfection 
Cells were seeded in 24-well plates at the initial density 30000 (HEK293 
and NIH3T3) or 60000 (HeLa) cells per well in 0.5 ml of DMEM. 24 hours later, 
cells were transfected with 0.5 µg of plasmid DNA per well. TurboFect 
(Fermentas) was used as the transfection reagent. TurboFect to DNA ratio was 
cell-line specific; 1 µl and 2 µl of TurboFect per 1 µg DNA were used in 
HEK293/NIH3T3 and HeLa cells, respectively.  
Corresponding amount of plasmid DNA and TurboFect were mixed in 0.1 
ml DMEM without FBS. The mixture was incubated 30 minutes at room 
temperature and then added dropwise directly to the cells. 1 ml of fresh DMEM 
culture media was added 6 hours post-transfection. Each transfection was 
performed at least in duplicates. Cells were collected 48 hours post-transfection 
and used for analysis. 
 
3.6.4 Dual Luciferase assay 
Knock-down effect produced by different vectors was measured by dual 
luciferase assay. Cells were transfected with a tested short hairpin-expressing 
plasmid, a plasmid expressing Renilla luciferase and a plasmid expressing firefly 
luciferase. Expression of one of the luciferases was specifically down-regulated 
with hairpin expressed from tested vector. The expression of the second luciferase 
was unaffected and served for normalization purposes.  
Analysis of variance (ANOVA) was used for statistical analysis of results 
(www.blatny.com/code/import.csv.files.and.run.single.factor.multiple.comparison.
anova.R). All ANOVA results (p-values) have been adjusted for multiple 
comparison. 
Cells were typically transfected with 50 ng of a firefly luciferase coding 
plasmid, 1 ng of a Renilla luciferase coding plasmid, 50 ng of a tested hairpin-
coding vector, and pBluescript up to the total DNA amount 500 ng per well. In 
some cases, different concentrations of a tested plasmid (20 – 450 ng) were 
transfected. Control transfection did not include an shRNA-expressing vector. 
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3.6.4.1 Plasmids used in this study 
pGL2 Control Vector (Promega)  
pGL4.10 (Promega, see appendix for map) with added promoter: 
• pGL4.10_SV40: SV40 promoter was amplified from pRL-SV40 
(Promega) and cloned between BglII and HindIII restriction sites 
pRL_SV40 (Promega, see appendix for map) and its modified variants:   
• pRL_SV40_mMos: mouse Mos cognate sequence was cloned into the 
XbaI site in the 3’UTR region of Renilla luciferase gene 
• pRL_SV40_ inverted_mMos: mouse Mos cognate sequence was cloned 
into the XbaI site in an inverted orientation 
pBluescript II KS (Stratagene, see appendix for plasmid map) 
 
3.6.4.2 Luciferases activity measurement  
Dual-Luciferase® Reporter Assay System (Promega) was used to measure 
luciferase activity. Cells were harvested 48 hours post-transfection. Cells were 
washed twice with 0.5 ml PBS. PBS was removed and 150 µl of Passive Lysis 
Buffer was added into each well. Plates were gently shaken for 20 minutes at room 
temperature. Lysed cells were collected into 1.5 ml microtubes and centrifuged for 
1 minute and 14 000 rpm using Centrifuge 5424 (Eppendorf). A 10 µl aliquot of 
each lysate was pipetted to a 96-well plate. Luciferases activity was measured 
using a luminometer Modulus Microplate (Turner BioSystems), which injected 50 
µl of each luciferase substrate to each sample during measurement. All reagents 
used were prepared according to the manufacturer’s instructions (Promega). 
 
3.6.5 Bradford protein assay 
In some experiments, total protein amount in the lysate was used to 
normalize results from luciferase assay. Bio-Rad Protein Assay Dye Reagent 
Concentrate (Bio-Rad) was used for protein measurement. Standards (Tab. 1) or 2 
µl of cell lysate were pipetted into 96-well plate. 200 µl of dye reagent (0.2x) was 
added to each well. After incubation for at least 5 minutes (no more than 1 hour), 
the absorbance was measured at 595 nm. 
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Protein amount (µg) corresponding to 1 µl of sample 
4  3  2  1.5  1  0.75 0.5 0.375  0.25  0.125  
Table 1: Standards used for Bradford protein assay 
Range of standard protein (IgG) concentrations used to construct the calibration curve. 
 
3.7 Transgenic mice  
3.7.1 Vector preparation for transgenesis 
To release the transgene from the TMP_ZP3_sh (see appendix for map) 
vector carrying the mouse Mos-targeting hairpin, the plasmid was cleaved with 
NotI and NdeI restriction enzymes. Fragments were separated by agarose gel 
electrophoresis. The functional cassette (~ 4.5 kbp long fragment) was excised and 
extracted from the gel by Gel Extraction Kit (Qiagen) and eluted to 500 µl H2O. 
The cassette was cleaned twice using DNA Clean & Concentrator kit (Zymo 
Research). The cassette purity was verified by agarose gel electrophoresis and 
given to the transgenic facility of Institute of Molecular Genetics Academy of 
Science of the Czech Republic.  
 
3.7.2 Oocyte microinjection and embryo transfer 
 Fertilized donor oocytes were obtained from super-ovulated 3-4 weeks 
old C57Bl/6N females (Charles Rivers Laboratories). Hormonal stimulation was 
carried out as follows: 5U of Pregnant Mare’s Serum Gonadotropine 
(PMSG/Folligon; Intervet) was injected into peritoneum. Forty-five hours later, 
5U of human Choriogonadotropine (HCG, Sigma) was injected into peritoneum 
and mice were mated with C57Bl/6N males. One day later, one-cell stage embryos 
were isolated from plugged females. 
 Pronuclear injection (PNI) of transgene DNA into male pronucleus was 
performed. Embryo transfer was performed either at one-cell stage directly after 
PNI or at the two-cell stage after an overnight culture. This was dependent on the 
amount of foster mice available on a specific day. 
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 Pseudopregnant CD1 females were used as foster mothers. Females were 
paired with vasectomized CD1 males (for optimal stimulation of the female) a 
night before the transfer. Embryos were transferred into oviduct (15-25 embryos 
per recipient, into one or both oviducts). The embryo transfer was done under 
sterile conditions on laminar bench in SPF (specified pathogen free) area of 
animal house. CD1 mice were obtained from in-house breeding. 
 
3.7.3 Genotyping 
The biopsies were obtained from 3-4 weeks old mice. GFP expression was 
analyzed by fluorescent stereomicroscope SZX16 (Olympus). Subsequently, tails 
were dissolved in one of the following lysis buffers. 
 
Buffer I:  
100 mM TRIS-HCl, pH 8.5 
5 mM EDTA  
0.2% SDS  
200 mM NaCl 
 
Buffer II: 
50 mM KCl  
10 mM TRIS-HCl, pH 8.3  
0.1 mg/ml gelatin  
0.45% NP 40  
0.45% Tween 20 
 
0.2 ml of lysis buffer supplemented with proteinase K (50:1) was added to 
each tail. Tails were shaken (700 rpm) in the mixing block MB-102 (Bioer) at 55 
°C until completely dissolved. Proteinase K was inactivated by incubation at 95 ºC 
for 10 minutes. When buffer I was used for the lysis, DNA was purified by the 
phenol-chloroform extraction (see 3.7.3.1 for details). Tails lysed in buffer II were 
used directly for PCR.   
PCR amplification of Mos hairpin sequence using ZP3_end.fwd and 
LMP_Rev_Seq primers and Taq DNA polymerase was performed. PCR 
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conditions were as follows: 94 ºC for 5 minutes; 40 cycles of 94 ºC for 30 seconds, 
57 ºC for 30 seconds, 72 ºC for 1 minute; 72 ºC for 10 minutes. PCR products 
were analyzed by electrophoresis using 1.5 % agarose gel.  
 
3.7.3.1 Phenol-chloroform extraction 
DNA from tails digested in lysis buffer I was subsequently purified by 
phenol-chloroform extraction. Samples were mixed with one sample volume of 
phenol solution equilibrated with 10 mM Tris HCl to pH 8.0 (Sigma Aldrich), 
mixed and centrifuged for 15 minutes at 12 000 rpm in centrifuge 5415R 
(Eppendorf) to separate the lower phenol and the upper water phase. The upper 
phase containing DNA was transferred and supplied with one volume of phenol 
and chloroform mixture (1:1) and mixed thoroughly. After centrifugation (15 
minutes, 12000 rpm), the upper phase was transferred and mixed with one volume 
of chloroform and centrifuged as previously. DNA from the upper phase was 
precipitated by adding 0.1 volume 3 M sodium acetate and 3 volumes ice-cold 
96% ethanol. The mixture was incubated at -20 °C for 10 minutes and then 
centrifuged as previously in a cooled centrifuge 5415R (Eppendorf). Supernatant 
was removed carefully and the pellet was washed by 1 ml of 70% ethanol. After 
centrifugation, the supernatant was removed and the pellet was dried and 
resuspended in 0.2 ml of water.  
 
3.7.4 Primary tail fibroblasts culture  
A small piece of mouse tail (about 0.5 cm) was minced by scalpel and 
resuspended in 10 ml of 1:1 mixture DMEM with PenStrep and collagenase (1 
mg/ml in PBS). The suspension was shaken for 1 hour at 37 ºC. The supernatant 
(after tissue sedimentation) was transferred to a clean tube. The fresh mixture of 
DMEM and collagenase was added to the rest of the sample and incubated as 
previously. The supernatant was collected and mixed with the previously collected 
one. The rest of the sample was stirred in 6 ml DMEM supplemented with FBS 
and PenStrep and cultured in 6 cm Petri dish at 37 ºC and 5% CO2. Collected 
supernatants were centrifuged for 5 minutes at 6000 rpm in the BR4i centrifuge 
(Jouan). The supernatant was discarded and the pellet was resuspended in 6 ml 
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DMEM supplemented with FBS and PenStrep and cultured in 6 cm Petri dish in 
37 ºC and 5% CO2.  
 
3.7.4.1 Puromycine resistance testing  
Primary tail fibroblasts from transgenic and wild type mice were cultured 
for at least five days. Then, medium was changed and puromycine was added to 
the final concentration 2.5 µg/ml. Cells were cultured at 37 ºC until the control 
cells (from wild-type mice) died. 
 
3.7.5 Oocyte isolation 
Eight weeks old mice were superovulated by intraperitoneal injection of 
0.1 ml (5 units) of PMSG (Folligon; Intervet). Forty-four hours after the injection, 
ovaries were isolated and placed in 4 ml of M2 medium supplemented with 4 µg 
of isobutylmethylxanthine (IBMX, 200mM). They were mechanically 
disintegrated to release cumulus-enclosed oocytes. Cumulus cells were removed 
with a thin glass capillary. Oocytes with germinal vesicle (GV) were washed 
three-times in M2 medium (approximately 0.2 ml) and twice in PBS. Oocytes 
were used for RT-PCR analysis or for maturation to the MII phase (in this case, 
IBMX was omitted).  
 
M2 medium (per 1L):  
Component g/l 
NaCl 5.53193 
KCl 0.35635 
CaCl2.2H2O 0.25137 
KH2PO4 0.162 
MgSO4 0.1649 
NaHCO3 0.35 
HEPES 5.42726 
Sodium lactate 3.31985 
Sodium pyruvate 0.0363 
D-Glucose 1 
Albumin, Bovine Fraction V 4 
Phenol Red 0.0106 
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3.7.5.1 Maturation to MII phase 
A few drops (60 – 80 µl) of CZB medium supplemented with glutamine (5 
µl of 3% glutamine per 1 ml CZB) were pipetted to a Petri dish. Drops were 
covered by paraffin oil to prevent evaporation. The dish was incubated at 37 ºC 
under 5% CO2 overnight. Next day, 5 – 8 oocytes (GV) were put into each drop 
and incubated at 37 ºC and 5% CO2 for 18 hours to mature to MII phase. 
 
CZB medium:  
Component per 1l 
bovine serum albumin (BSA) 5 g 
CaCl2.2H2O 0.251 g 
D-Glucose 1 g 
KCl 0.36 g 
KH2PO4 0.16 g 
L-glutamine 0.146 g 
MgSO4.7H2O 0.29 g 
NaCl 4.77 g 
NaHCO3 2.11 g 
sodium lactate 5.848 ml 
sodium pyruvate 0.029 g 
Penicillin G 100,000 U 
phenol red 0.01 g 
streptomycin sulfate 0.1 g 
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4 Results 
The results are presented in four sections:  
1. In the first section, I performed comparative study of various available 
systems mediating RNAi via short hairpin (shRNA) expression to confirm 
that vectors selected for our system construction (pTMP and pLMP) have a 
potential to down-regulate target gene efficiently. 
2. In the second section, I made few changes in selected pTMP and pLMP 
vectors to make them compatible with oocyte-specific expression.  
3. I the third section, I designed and selected the most efficient shRNA 
sequences targeting Mos gene. The best anti-Mos shRNA was cloned into 
prepared vector and used to make transgenic mice. 
4. In the last section, obtained transgenic mice were bred and their phenotype 
was analyzed. 
 
4.1 Vector selection 
Various short hairpin RNA-expressing systems mediating RNAi have been 
described. We decided to base our system on pLMP and pTMP vectors.  
pTMP and pLMP vectors express miRNA-like hairpin derived from 
endogenous miR-30 driven by tetracycline-regulated cytomegalovirus (CMV) 
promoter and viral long terminal repeat (LTR) promoter, respectively. Both 
vectors also express EGFP and puromycine resistance genes driven by PGK 
promoter. 
We compared the functionality of these plasmids to other systems to assure 
the selected vectors are optimal for down-regulation target genes. Altogether, we 
compared six expression systems (Tab. 2), four of them expressing miRNA-like 
hairpins and two of them expressing class I hairpins. We also compared the 
efficacy of modified pLMP and pTMP vectors (containing loxP and NotI sites; 
described later in the chapter 4.2) with other systems.  
Short hairpins targeting firefly luciferase were cloned into tested vectors. 
siRNA sequence was adopted from the literature (Elbashir, et al., 2001a). 
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Vector name Hairpin type Reference 
pLMP miRNA-like (class II) Open Biosystems 
pTMP miRNA-like Open Biosystems 
pTRIPZ miRNA-like Open Biosystems 
pUI2-GFP-SIBR miRNA-like (Chung, et al., 2006) 
pSuper.retro.puro shRNA (class I) OligoEngine 
pSuper2xTRE shRNA unpublished plasmid, a 
gift from J. Jaworski 
Table 2: Vectors used for the comparative study 
A list of available vectors used for shRNA expression, whose functionality was tested in 
our assays. See appendix for maps of these vectors. 
 
For hairpin cloning to pTRIPZ, pLMP/pTMP vectors and their loxP 
variants we designed 97 nt long oligonucleotide FL_1 (for sequences see the 
chapter 3.2) containing miRNA-like hairpin sequence. Insert preparation and 
cloning procedure was performed as described in the manufacturer’s manual 
(Open Biosystems, http://www.openbiosystems.com/collateral/ 
rnai/pi/LMP-TMP%20vector%20product%20insert_Glycerol.pdf). Briefly, hairpin 
inserts were amplified by PCR using LMP_oligo.fwd and LMP_oligo.rev primers. 
PCR products and vectors were cleaved by EcoRI and XhoI restriction enzymes 
and ligated together.  
The insert for cloning into pSuper and pSuper2xTRE vectors was prepared 
by annealing oligonucleotides FL_2 and FL_3 (for sequences see the chapter 3.2). 
Annealed oligonucleotides were cloned into BglII and HindIII sites of target 
vector. 
Hairpin cloning to the UI2-GFP-SIBR vector was performed similarly to 
the cloning into the pSuper vector. Annealed oligonucleotides FL_4 and FL_5 (for 
sequences see the chapter 3.2) were ligated with a BpiI-cleaved vector. 
We compared the performance of pTMP, pLMP vectors and their loxP 
variants with pSuper.retro.puro and pSuper 2xTRE vectors using dual luciferase 
assay. The experiment was performed in HEK293 and HeLa cells. HeLa cells 
were transfected by 100 ng pGL2, 2 ng pRL_SV40, 10 or 50 or 200 ng tested 
plasmid. HEK293 cells were transfected by 100 ng pGL2, 1 ng pRL_SV40, 10 or 
50 or 200 ng tested plasmid. pBluescript was added to all transfections to make 
total DNA amount up to 500 ng per well (if not otherwise noted, pBluescript was 
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used as a stuffer plasmid in all experiments). All transfections were performed in 
duplicates. 
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Figure 3: Plasmids efficacy test. 
Different concentrations of tested shRNA-expressing vectors were co-transfected with 
reporter plasmids (pGL2) in (A) HEK293 and (B) HeLa cells. Luciferase activity was 
measured by dual luciferase assay. Measured values were normalized to protein content 
measured by Bradford method. Firefly luciferase activity was normalized to control Renilla 
luciferase (pRL_SV40 plasmid). Firefly luciferase activity in control sample (omitting 
shRNA-expressing plasmid) was set to 100%. Data are expressed as an average +/- SEM 
(standard error of the mean). All tested samples were significantly down-regulated 
compared to the control (ANOVA; p< 0.001). 
 
 
 In HEK293 cells, all tested vectors significantly down-regulated reporter 
activity; pTMP and pLMP vectors performed better compared to pSuper.retro.puro 
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and pSuper2xTRE plasmids. The effect of all plasmids in HEK293 cells was 
concentration-dependent (Fig. 3 A). The loxP variants performed similarly as 
original pTMP/pLMP vectors (but variants of both vectors - 10 ng and pTMP 
variants - 50 ng and significantly differed, ANOVA, p< 0.01). In HeLa cells, the 
effect of all plasmids was similar but less pronounced compared to HEK293 cells. 
because However, the highest concentration of shRNA-expressing plasmid did not 
show the highest level of down-regulation suggesting that saturation effect may 
exist at concentrations above 50 ng in HeLa cells (Fig. 3 B). 
After cloning appropriate UI2_GFP_SIBR and pTRIPZ derivates, we 
repeated the experiment with all vectors (Fig. 4). In contrast to the previous 
experiment, only single concentration of shRNA-expressing plasmids was used. 
HEK293 and HeLa cells were transfected by 100 ng of pGL2, 1 ng of pRL_SV40 
and 50 ng of tested vectors. Transfections were performed in quadruplicates. 
Variants of tested vectors expressing shRNA targeting an irrelevant gene were 
used as negative controls to verify the specificity of firefly luciferase down-
regulation (Fig. 4 B, D).  
 In HEK293 cells, all tested vectors specifically down-regulated luciferase 
reporter activity (Fig. 4 A). UI2_GFP_SIBR plasmid was similarly potent as 
pTMP/pLMP vectors, down-regulating the activity by ~ 80%. pTRIPZ and 
pSuper2xTRE plasmids performed worse, down-regulating the activity only by ~ 
40%. (Fig. 4 A).  All tested plasmids, except the pSuper2xTRE, significantly 
down-regulated luciferase activity in absence of anti-firefly hairpin that reflects 
non-specific effects (Fig. 4 B). The extent of non-specific action of pTRIPZ vector 
was similar to its “specific” down-regulation, suggesting its malfunction. The non-
specific effects of other plasmids were acceptable compared to the level of their 
specific down-regulation (Fig.4 A, B).  In HeLa cells, the effect of all plasmids 
was similar but less pronounced compared to HEK293 cells. pTRIPZ vector did 
not down-regulate reporter activity (Fig. 4 C). No plasmids showed any non-
specific effect in HeLa cells (Fig. 4 D). 
We observed cell line-dependent effects of shRNA-expressing plasmids. 
The level of down-regulation was higher in HEK293 compared to HeLa cells. 
Less efficient transfection of HeLa cells (assayed by flow cytometry after EGFP 
transfection; unpublished results) could explain observed differences in down-
regulation efficiency. However, absolute values of control Renilla luciferase 
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activity were higher in HeLa cells (data not shown) suggesting that promoter 
activity is cell-line dependent and may influence the outcome of luciferase assay. 
The cell line-differences may be influenced by amount of shRNA expressed in 
individual cell lines. However, the amount of expressed shRNAs was not directly 
evaluated.  
Together, loxP variants of pTMP/pLMP vectors selected for generation of 
our new system worked satisfyingly and are suitable for anti-Mos shRNA cloning 
and transgenesis. 
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Figure 4: Luciferase assay comparing functionality of short hairpin-coding 
plasmids 
50 ng of tested anti-firefly shRNA-expressing vectors was co-transfected with reporter 
plasmid (pGL2) in (A) HEK293 and (C) HeLa cells to test vectors efficacy. The same 
amount of tested vectors expressing an irrelevant shRNA was co-transfected with reporter 
plasmid (pGL2) in (B) HEK293 and (D) HeLa cells to test vectors specificity. Luciferase 
activity was measured by dual luciferase assay. Measured values were normalized to 
protein content in particular samples measured by Bradford method. Firefly luciferase 
activity was normalized to control Renilla luciferase (pRL_SV40 plasmid). Firefly 
luciferase activity in control sample (omitting shRNA-expressing plasmid) was set to 
100%. Data are expressed as an average +/- SEM (standard error of mean). * p< 0.001;** 
p<0.05 (ANOVA) 
 
*
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4.2 Construction and testing of miRNA-like hairpin expressing 
vector 
Retroviral vectors pTMP and pLMP (Open Biosystems; see appendix for 
plasmid maps) were used for construction of our oocyte-specific shRNA-
expressing system. 
We made the following changes in pLMP and pTMP vectors (Fig. 5). We 
inserted sequences containing NotI restriction site and loxP site behind the 5´UTR 
and behind EGFP gene. All four oligonucleotides used for the construction 
(5´loxP.fwd, 5´loxP.rev, 3´loxP.fwd and 3´loxP.rev; for sequences see the chapter 
3.2) were phosphorylated and annealed. The 5´loxP insert was cloned into BglII 
site behind the 5´UTR and the 3´loxP insert was cloned into SalI site behind the 
EGFP gene. Only one BglII site downstream the 5´loxP insert was kept. This site 
was subsequently used for ZP3 promoter insertion. 
 
 
 
Figure 5: Construction of pLMP_loxP vector 
Schematic representation of changes made in the parental pLMP plasmid. NotI and loxP 
sites were inserted behind the 5´LTR and before the 3´LTR to flank functional cassette 
expressing shRNA and marker genes. EcoRI restriction site present within shRNA 
insertion site in the original plasmid was mutated to MunI site. Identical changes were 
performed in pTMP plasmid simultaneously (new system was constructed from functional 
transgenic cassette from pLMP and retroviral sequences from pTMP, which is self-
inactivated vector. Oocyte-specific ZP3 promoter was inserted between loxP and MunI 
sites in pLMP to get pLMP_ZP3_sh. The NotI-flanked cassette was transferred to 
pTMP_loxP to get pTMP_ZP3_sh. 
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NotI sites allow for releasing the functional transgenic cassette for 
microinjection in a simple digest. LoxP sites allow for site-specific Cre-mediated 
recombination. Cre-loxP recombination provides an alternative way of 
transgenesis, such as recombination into loxP sites integrated in the genome of 
specific embryonic stem lines. Cre-loxP recombination may be also used for the 
phenotype rescue to reveal unspecific phenotypes. If phenotype remains 
unchanged after recombination (only loxP sites retained in the genome after 
recombination), an observed phenotype likely arises from the disruption of a gene, 
in which the transgene has been inserted, not by the transgene itself.  
The functionality of loxP sites was tested in bacteria expressing the Cre 
recombinase. A plasmid part flanked by loxP sites was efficiently excised during 
Cre-mediated recombination and bacteria would produce shorter plasmid. Both 
plasmids pLMP_loxP and pTMP_loxP were chemically transformed into the Cre 
recombinase-expressing E. coli strain (obtained from Sylvia Arber, FMI, Basel).  
 
A)      B) 
    
 
Figure 6: Test of LoxP sites functionality  
pTMP_loxP (panel A) and pLMP_loxP (panel B) plasmids were transfected to Cre 
recombinase-expressing bacterial strain. Plasmids were isolated and linearized by 
restriction digestion. Sizes of linearized original and recombined plasmids were compared 
using agarose gel electrophoresis.  
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Recombined plasmids were linearized by HindIII cleavage and original 
plasmids were linearized by EcoRI cleavage. The size of original and recombined 
plasmids was compared on agarose gel electrophoresis. pLMP and pTMP 
recombined plasmids were about 3 kbp and 3.5 kbp in length shorter compared to 
parental plasmids, respectively. Plasmid size reduction confirmed the functionality 
of inserted loxP sites (Fig. 6). 
To achieve oocyte-specific expression of shRNA, ZP3 promoter was 
inserted into the pLMP_loxP vector. The ZP3 promoter could guarantee robust 
oocyte-specific shRNA expression, which may be sufficient to effectively down-
regulate Mos mRNA. Unfortunately, ZP3 promoter contains several EcoRI sites, 
which are used for shRNA insertion in the original pTMP and pLMP vectors. As 
the shRNA insertion site has to be unique, we replaced EcoRI site with MunI, 
which generates overhangs compatible with EcoRI and it allows for cloning the 
same oligonucleotides designed for original pLMP/pTMP vectors. Primers 
LMP_MunI.fwd and LMP_MunI.rev (for sequences see the chapter 3.2) were used 
for mutagenesis.  
We inserted ZP3 promoter into pLMP_loxP_MunI to get pLMP_ZP3_sh. 
Sequence of ZP3 promoter was amplified from a ZP3-containing plasmid used in 
a previous transgenic RNAi experiment (Stein, et al., 2003) by PCR using primers 
ZP3_BglII_Fwd and ZP3_BglII_Rev (for sequences see the chapter 3.2). The PCR 
product and the pLMP_loxP_MunI vector were cleaved by BglII and the plasmid 
was dephosphorylated. Plasmid and amplified ZP3 promoter were ligated together. 
Insertion was verified by restriction analysis using BamHI and XhoI. To avoid 
mutations in the ZP3 promoter, pLMP_ZP3_sh clones were sequenced using 
LMP_Rev_Seq and LMP_Fwd_Seq primers (for sequences see the chapter 3.2).  
Direct insertion of ZP3 promoter into pTMP_loxP_MunI instead of TRE-
CMV promoter would be complicated due to absence of unique restriction site 
immediately behind the TRE-CMV promoter. Thus, the functional ZP3 cassette 
from pLMP_ZP3_sh was transferred into pTMP_loxP_MunI using NotI digestion 
to get pTMP_ZP3_sh. pTMP_ZP3_sh plasmid was constructed for the case of 
using retroviral transduction for transgene delivery. In contrast to pTMP, pLMP is 
not self-inactivating (SIN) retroviral vector and strong promoter present in the 
5´LTR region could influence shRNA expression. Construction of pTMP_ZP3_sh 
plasmid will guarantee that only ZP3 promoter will drive the hairpin expression. 
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The final pTMP_ZP3_sh construct was used for cloning functional Mos-targeting 
shRNA and transgenesis. 
 
4.3 Mos siRNA sequence selection 
Mos gene was successfully down-regulated by transgenic RNAi mediated by 
long RNA hairpin. Mos down-regulation resulted in parthenogenetic activation of 
oocytes (Stein, et al., 2003). The absence of MOS leads to disruption of the second 
meiotic block and parthenogenetic activation of oocyte. The second polar body is 
extruded and mouse is infertile. We decided to test our pTMP_ZP3_sh system on 
the Mos gene, because the characteristic phenotype observed long hairpin 
application allows comparing the effects of long and short hairpin-mediated RNAi 
in oocytes. 
Eight various miRNA-like shRNA sequences targeting mouse Mos 
(NM_020021.2) were designed (Tab. 3). Mos_1 and Mos_2 hairpin sequences 
originally designed for pTER plasmid (J. Filkowski, unpublished results) were 
extended to miRNA-like shRNAs using RNAi Oligo Retriever 
(http://katahdin.cshl.org:9331/homepage/siRNA/RNAi.cgi?type=shRNA). Other six 
Mos hairpin sequences were designed using RNAi Codex database (Olson, et al., 
2006),  BIOPREDsi (Huesken, et al., 2005), RNAxs (Tafer, et al., 2008) and 
RNAi Oligo Retriever prediction algorithms. Different algorithms predict different 
siRNA sequences. There is higher probability that a siRNA will be efficient when 
predicted by more algorithms. In any case, reliability of prediction algorithms is 
not absolute and all selected siRNAs have to be experimentally tested to reveal the 
most efficient one. 
Hairpin Sequence 
Mos 1 CACGACAACATAGTTCGGGTTG 
Mos 2 CCCGAAGACTCCAACAGCCTAG 
Mos A CGGAGATCCTGAAAGGAGAGAT 
Mos B TCCATAGACTGGGAACAGGTAT 
Mos C GAGGGTTTGGCTCGGTGTATAA 
Mos D TCCGGAGATCCTGAAAGGAGAG 
Mos E CTCGGTGTATAAAGCCACTTAC 
Mos F AGGGTTTGGCTCGGTGTATAAA 
 
Table 3: Selected shRNA targeting mouse Mos mRNA 
Mos target sequences of selected short hairpins are shown. Bold letters indicate originally 
designed 19 bp long sequences (J. Filkowski, unpublished results). 
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We used corresponding siRNA sequences to design 97 nt long 
oligonucleotides Mos_1, Mos_2, Mos_A-F as is described in pLMP/pTMP 
manual (Open Biosystems, http://www.openbiosystems.com/collateral/rnai/pi/ 
LMP-TMP%20vector%20product%20insert_Glycerol.pdf). Inserts were prepared 
by PCR using LMP_oligo.fwd and LMP_oligo.rev primers (for sequences see the 
chapter 3.2) adopted from the manufacturer’s manual. PCR product was cleaned 
using DNA Clean & Concentrator kit (Zymo Research), cleaved by EcoRI and 
XhoI restriction enzymes, and cloned to pLMP_loxP and pTMP_loxP plasmids. 
Hairpins effects were tested in HeLa, HEK293 and NIH3T3 cells. The final 
version of developed vector, pTMP_ZP3_sh, was not used for the test, because the 
oocyte-specific ZP3 promoter is not active in somatic cell lines. The efficacy of 
each Mos shRNA was measured using dual luciferase assay. 
In the first experiment, the efficacy of Mos_1 and Mos_2 hairpins was 
tested. HEK293 cells were transfected with 100 ng of pGL4.10_SV40, 50 ng of 
pRL_SV40_mMos and 20, 50 or 150 ng of hairpin-expressing pLMP_loxP or 
pTMP_loxP plasmids. In contrast to other experiments, Nanofectin reagent (PPA) 
was used for transfections (150 µl Nanofectin solution per sample). Transfection 
was performed in triplicates.   
Only pTMP_LoxP_Mos_1 and pLMP_LoxP_Mos_2 at the concentration 
20 ng per well significantly down-regulated reporter activity by ~ 50 - 60 % (Fig. 
7). Remaining vectors did not work at any concentration tested. Higher plasmid 
concentration should result in increased reporter activity down-regulation. In this 
experiment, increasing plasmid concentration showed no tendency to enhance 
down-regulation of reporter activity suggesting that tested hairpins were non-
functional. These results were rather surprising since originally constructed 
pTER_Mos_1/2 plasmids had been functional in previous experiments (J. 
Filkowski, unpublished results). 
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Figure 7: Test of Mos_1 and Mos_2 shRNA hairpins 
Different concentrations of tested shRNA-expressing vectors were co-transfected with 
reporter plasmid (pRL_SV40_mMos) in HEK293 cells. Luciferase activity was measured 
by dual luciferase assay. Renilla luciferase activity was normalized to control firefly 
luciferase (pGL4.10_SV40 plasmid). Renilla luciferase activity in control sample (omitting 
shRNA-expressing plasmid) was set to 100%. Data are expressed as an average +/- SEM 
(standard error of mean). * p< 0.05 (ANOVA). 
 
Subsequently, we compared pLMP/pTMP_loxP_Mos_1/2 plasmids direct 
with originally constructed pTER_Mos_1/2 plasmids in a single experiment. This 
test was performed in HEK293 and HeLa cells. Cells were transfected with 150 ng 
of pGL4.10_SV40, 20 ng of pRL_SV40_mMos and 50, 150 or 450 ng of 
Mos_1/2-expressing pLMP/pTMP_loxP or pTER plasmids. Transfections were 
performed in duplicates.   
Results from HeLa cells suggested that only pTER_Mos_2 down-regulated 
Renilla luciferase activity by ~ 20 – 40 % in a concentration-dependent manner. 
However, the reduction of reporter activity was statistically significant only at the 
highest pTer_Mos_2 concentration. Remaining vectors did not work at any 
concentration tested (Fig. 8 A).  
Similar results were obtained from HEK293 cells (Fig. 8 B). The apparent 
down-regulation (by ~ 40-50%) present in all samples is probably caused by an 
erroneous measurement of luciferase activity in control samples (Fig.8 B; note 
high SEM values). In HEK293 cells, only pTer_Mos_2 significantly down-
regulated reporter activity at all concentrations tested (ANOVA; p< 0.05). 
 
*
*
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Figure 8: Comparison of Mos_1 and Mos_2 hairpins expressed from 
pLMP/pTMP_loxP and pTER plasmids. 
HeLa (A) and HEK293 (B) cells were co-transfected with different concentrations of tested 
shRNA-expressing vectors and reporter plasmids (pRL_SV40_mMos, pGL4.10_SV40). 
Luciferase activity was measured by dual luciferase assay. Renilla luciferase activity was 
normalized to control firefly luciferase. Normalized Renilla luciferase activity in control 
sample (without shRNA-expressing plasmid) was set to 100%. Data are expressed as an 
average +/- SEM. * p< 0.05 (ANOVA). 
 
*
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Based on these results, we decided not to use Mos_1 and Mos_2 shRNA 
hairpins for transgenesis and decided to design and test additional hairpins, 
Mos_A–F.  
Cells were transfected with pRL_SV40_mMos to elicit hairpin efficacy as 
in the previous experiment. Moreover, we also performed sense strand loading test 
using plasmid expressing Renilla luciferase tagged with an inverted cognate Mos 
mRNA sequence (pRL_SV40_inverted_mMos). The RISC complex should be 
preferentially loaded by the anti-sense strand of shRNA depending on the shRNA 
thermostability. shRNA sequences are designed to be less stable at their 5´end of 
anti-sense strand to support its preferential loading. Potentially loaded sense 
strand, which has no specific target in the cell, could bind to many partially 
homologous mRNAs and down-regulate their expression eventually leading to an 
unspecific phenotype. Control pRL_SV40_inverted_mMos plasmid should detect 
loading of sense strand on the RISC complex.   
Cells were transfected with 50 ng LMP loxP expressing hairpins Mos_A–
F, 50 ng pGL4.10_SV40 and 1 ng pRL_SV40_mMos (or 
pRL_SV40_inverted_mMos). Transfection was performed in quadruplicates. 
Efficacy test was performed using HEK293, HeLa and NIH3T3 cells. Sense strand 
loading test was performed using HEK293 and NIH3T3 cells.  
Hairpins Mos_A and D did not down-regulate reporter activity in any cell 
lines used (Fig. 9). Hairpins Mos_C, E and F significantly down-regulated Renilla 
expression by ~ 40-60 % in HEK293 and NIH3T3 cells (Fig. 9 A, C). In HeLa 
cells, only Mos_F hairpin down-regulated Renilla activity by more than 40 % 
(Fig. 9 B). Mos_B hairpin significantly down-regulated reporter expression in all 
cell lines but only by approximately 20 % (Fig. 9). 
No hairpin affected reporter Renilla activity in the sense strand loading test 
(Fig. 10) suggesting that all selected hairpins targeted specifically Mos mRNA and 
shRNA sense strand was not loaded on the RISC complex.  
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Figure 9: Mos hairpins efficacy test. 
HEK293 (A), HeLa (B) and NIH3T3 (C) cells were transfected with Mos hairpin-
expressing plasmid, firefly luciferase coding plasmid and Mos-tagged Renilla luciferase 
plasmid. Activity of both luciferases was measured by dual luciferase assay. Renilla 
luciferase activity was normalized to control firefly luciferase. Normalized Renilla 
luciferase activity in control sample (without shRNA-expressing plasmid) was set to 100%. 
Data are expressed as an average +/- SEM. * p<0.001; ** p<0.05 (ANOVA) 
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Figure 10: Mos hairpins sense strand loading test 
Plasmids coding shRNA, firefly luciferase and Renilla luciferase tagged with inverted Mos 
sequence were co-transfected into HEK293 (A) and NIH3T3 (B) cells. Activity of 
luciferases was measured by dual luciferase assay. Renilla luciferase activity was 
normalized to control firefly luciferase. Normalized Renilla luciferase activity in control 
sample (without shRNA-expressing plasmid) was set to 100%. Data are expressed as an 
average +/- SEM.  
 
Finally, we tested the concentration dependency of shRNA-expressing 
vector. NIH3T3 mouse fibroblasts were transfected with 50 ng, 150 ng or 450 ng 
LMP_loxP_Mos_A, B, C, E or F (non-functional Mos_D was omitted), 50 ng 
pGL4.10_SV40 and 1 ng pRL_SV40_mMos. Transfection was performed in 
triplicates.  
Observed shRNA-mediated down-regulation of reporter Renilla plasmid 
was slightly concentration-dependent up to 150 ng of shRNA-expressing plasmids 
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(Fig. 11). However, significant non-specific down-regulation of control firefly 
luciferase activity was observed at higher concentrations used (data not shown). 
Our unpublished data suggested that global transfection efficacy decreases when 
growing amount of a large plasmid (such as pLMP_loxP) is used in transfections. 
Nevertheless, the data confirmed that the Mos_F and Mos_C were the most 
functional hairpins.  
We decided to use the hairpin Mos_F (it appeared to be more functional in 
previous experiment - Fig. 9) for further cloning into the pTMP_ZP3_sh vector 
and making transgenic animals.  
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Figure 11: Concentration dependency test of Mos-targeting shRNAs  
NIH3T3 fibroblasts were transfected with three concentrations of shRNA-expressing 
plasmid and stable amount of luciferase reporter plasmids. Activity of Renilla and firefly 
luciferase was measured by dual luciferase assay. Renilla luciferase activity was 
normalized to control firefly luciferase. Normalized Renilla luciferase activity in control 
sample (without shRNA-expressing plasmid) was set to 100%. Data are expressed as an 
average +/- SEM. All values were significantly lower compared to the control (ANOVA; 
p<0.05).   
 
4.4 Transgenic mice analysis 
Mos_F hairpin was cloned into the pTMP_ZP3_sh plasmid. Functional 
shRNA-expressing cassette, released by NotI digestion, was given to the 
transgenic facility, where it was microinjected into male pronucleus. One- or two-
cell stage embryos were transferred to the oviducts of stimulated foster mothers.  
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4.4.1 Genotyping 
Overall, we obtained 56 mice. EGFP expression in mouse tails was 
screened under the microscope. EGFP expression should be apparent in all tissues 
of transgenic mice, because EGFP expression is under the control of PGK 
promoter in contrast to shRNA expression, which is driven by oocyte-specific ZP3 
promoter. However, no mouse had EGFP-positive tail.  
 
A)        B)     
  
C)  
 
D)           E) 
     
 
Figure 12: Mouse tail genotyping 
Mice were genotyped by PCR using primers specific for inserted DNA. Five rounds of 
genotyping were performed (A-E) as tail biopsies were obtained from the mouse facility. 
Specific product is ~ 500 nt long. GeneRuler 100bp DNA Ladder (Fermentas) was used 
as a standard for size determination. 
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 Then, tails were lysed and genotyping by PCR was performed using 
transgene-specific LMP_Rev_Seq and ZP3_end.fwd primers (for sequences see 
the chapter 3.2). Six transgenic mice were detected (Fig. 12). Four males and one 
female were strongly PCR-positive, the second female was weakly positive. 
 
4.4.2 Analysis of transgenic markers 
There are several possible reasons, why tails of transgenic mice were 
EGFP-negative. A transgene may be inserted in a transcriptionaly inactive region 
or silenced as a parasitic sequence. Other reason may be an altered EGFP 
expression. EGFP is expressed as the second gene together with puromycin 
resistance in a bi-cistronic transcription unit driven by the PGK promoter. If IRES 
or PGK promoter were functionally altered, EGFP would not be expressed. 
Hairpin expression is driven by an independent ZP3 promoter so the EGFP 
absence does not automatically mean that the shRNA hairpin is not expressed.  
To confirm silencing of transgene, primary tail fibroblasts were isolated 
from transgenic mice and treated with puromycine. Simultaneously, primary 
cultures were prepared from wild type mice as controls. No puromycine-resistant 
fibroblasts were obtained neither from transgenic nor from wild-type animals. 
These results suggest that at least the expression of marker genes is disrupted. 
However, the expression status of shRNA should be determined directly only in 
oocytes, because shRNA is not expressed in any other tissues. 
 
4.4.3 Mice breeding 
Transgenic mice were interbred with wild type C57Bl/6NCrl mice. We 
expected transgenic females to be infertile (in the case of complete Mos down-
regulation) or have decreased fertility (in the case of partial Mos disruption). 
Moreover, both transgenic females we obtained gave birth as frequently as wild 
type females. Number of pups (about 8) in litters was also comparable to wild type 
females. 
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4.4.4 Oocyte analysis 
Oocytes were isolated from one transgene-positive and one transgene-
negative female offspring of transgenic male No. 819. The Mos phenotype and 
Mos mRNA expression levels were analyzed in isolated oocytes. 
Analysis of offspring of other transgenic mice is in progress. 
 
4.4.4.1 Oocyte maturation 
Several isolated oocytes (in GV phase) were moved to CZB medium 
supplemented with glutamine and let mature to elicit whether fraction of 
transgenic oocytes undertake parthenogenetic activation. Moreover, oocytes from 
transgenic as well as wild-type animals matured only to MII phase suggesting that 
the second meiotic block was maintained and the Mos gene is functional in 
transgenic animals. 
 
4.4.4.2 qPCR 
 Hypothesis that Mos is partially down-regulated but not enough to cause 
the null phenotype was tested by qPCR. Mos mRNA expression levels were 
analyzed in individual oocytes isolated from transgenic and control mice. Four 
transgenic and seven wild-type oocytes were used for single cell RT-PCR. 
Reverse transcriptase was omitted in one sample from each group. This “minus 
RT” (-RT) control allowed to distinguish PCR fragment amplified from cDNA 
and genomic DNA. In the case of Mos analysis, the (-RT) control is necessary, 
because Mos is an intron-less gene and genomic DNA is amplified together with 
cDNA. Rabbit β-globin mRNA was added into each sample and amplified as an 
external standard. 
 Results showed non-significant difference in Mos mRNA expression from 
transgenic oocytes compared to control ones (relative expression = 0.59; p = 
0.305) suggesting that the integrated transgene was non-functional, probably due 
to complete silencing of its expression.  
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Figure 13: Mos relative expression in transgenic oocytes 
Mos mRNA amount was analyzed by single-cell qPCR. Rabbit β-globin was used as an 
external standard. Data indicate relative Mos expression in transgenic oocytes compared 
to wild-type oocytes. Results were analyzed using the REST 2008 software.  
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5 Discussion 
 Up to now, only systems expressing long hairpin RNAs have been used for 
transgenic RNAi experiments in mouse oocytes (Coumoul, et al., 2005; Stein, et 
al., 2003; Yu, et al., 2004). Time-consuming preparation of long hairpin RNA-
expressing vectors is the main disadvantage of this system. We have prepared 
pTMP_ZP3_sh vector mediating transgenic RNAi in oocytes via the expression of 
miRNA-like short hairpin RNAs that should overcome the disadvantages of long 
hairpin-expressing system.  
pTMP_ZP3_sh vector is derived from commercial pTMP and pLMP vectors. 
Vector efficacy may be influenced by several factors as hairpin type and its 
sequence, promoter type or target cell type used. Our comparative study of 
different shRNA-expressing systems suggests that majority of plasmids expressing 
the class II hairpins (miRNA-like hairpins) work better compared to the class I 
hairpin-expressing plasmids. Original pLMP, pTMP vectors and their loxP 
variants constructed during this thesis significantly down-regulated target gene 
expression in transient transfection assays. These results strongly supported the 
usage of miRNA-like hairpin for development of our oocytes-specific expression 
system.  
 The final version of our expression vector, pTMP_ZP3_sh, could not be 
directly tested in cell culture because of strong oocyte-specific activity of ZP3 
promoter. However, ZP3 promoter was successfully used in several studies for 
RNAi in oocytes and guarantees sufficient gene expression in transgenic animals 
(Stein, et al., 2003; Yu, et al., 2004). 
The advantage of pTMP_ZP3_sh vector is that two markers, EGFP and 
puromycine resistance, are expressed in all tissues providing easy recognition of 
transgenic mouse (EGFP positivity), while the hairpin is expressed only in 
oocytes. In addition, this vector can be delivered into oocytes or other cells by 
three different approaches: (a) via microinjection of linearized cassette into the 
zygote or oocytes, (b) via Cre-loxP recombination into stem cells or (c) via 
retroviral transduction. LoxP sites contained in pTMP_ZP3_sh vector provide an 
option to perform a rescue experiment, which could reveal potential false positive 
phenotype arising from a disruption of any gene caused by transgene insertion.  
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We tested pTMP_ZP3_sh vector by targeting Mos dormant maternal 
mRNA, which was commonly studied using RNAi. We selected and tested several 
short hairpins targeting Mos and the best one, Mos_F, was used to establish 
transgenic mouse line. We obtained fifty-six mice but only six of them carried 
integrated transgene. Unfortunately, none of them expressed EGFP in somatic 
cells. Moreover, primary fibroblasts isolated from transgenic mouse tail were not 
resistant to puromycine suggesting that the whole transgene was silenced. While 
marker genes expression is driven by the PGK promoter, hairpin expression in 
driven by the strong oocyte-specific ZP3 promoter, which is not active in somatic 
tissue. Thus, the possible functional expression of shRNA in oocytes cannot be 
excluded solely based on these results. 
Previous experiments revealed that mouse females with down-regulated 
Mos were infertile (Stein, et al., 2003). Both transgenic females we obtained gave 
birth to pups indicating that the transgene is non-functional. It was still possible 
that the hairpin is expressed in oocytes, but the expression level is insufficient to 
cause Mos null phenotype. However, there was no significant difference in Mos 
mRNA amount in transgenic and wild type oocytes. Together, these results 
suggested that the transgene was completely silenced. Although the transgene is 
under the control of a strong promoter, the local environment at the integration site 
can significantly influence the transgene expression (reviewed in Matthaei, 2007). 
However, it is unlikely that all six animals we have obtained would have suffered 
from such inactivation. 
 Linear pieces of DNA, similar as pTMP_ZP3_sh fragment used in our 
study, used for transgenesis integrate into genome randomly and preferentially in 
tandems, not as a single copy (reviewed in Matthaei, 2007). This possible 
unfavorable effect would be eliminated in transgenesis using viral transduction, 
which provides a single copy integration. The vector used in our study is of 
retroviral origin and thus lacks any introns. On the other hand, mammalian 
genome is rich in intronic sequences and intron-less regions are frequently 
recognized as parasitic sequence, which may be silenced by epigenetic 
mechanisms (reviewed in Matzke, et al., 2000). Up to now, viral transduction of 
our vector has not been performed and is a possibility for future studies. 
In any case, all performed experiments suggest that our new expression 
system is not mediating efficient transgenic RNAi in mouse oocytes. Whether 
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vector sequence itself or other events (such as mouse strain used for transgenesis) 
are a reason of transgene failure will be further analyzed. 
Our work also suggests that the construction of short hairpin-expressing 
vector is not advantageous compared to the preparation of long hairpin plasmids. 
Short shRNA cloning is easier, but the proper selection of efficient shRNAs is 
time-consuming and costly. Not all designed short hairpins are really functional in 
vitro and in vivo and it is necessary to design more short hairpins and to test their 
efficiency throughoutly. On the other hand, the long hairpin is usually functional 
regardless of the sequence (Coumoul, et al., 2005; Stein, et al., 2003; Yu, et al., 
2004). Moreover, even the most rigorously selected short hairpin RNA shows off-
targeting effects while long hairpin is practically free of non-specific action in 
oocytes (Stein, et al., 2005).  
We conclude that long hairpin-expressing vectors remain the most suitable 
tool for RNA interference-based functional studies in oocytes. Short hairpin-
expressing systems are alternative approaches when the long-hairpin expression 
cannot be used. 
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